CLINICAL_TRIALS
research
· 2026-03-03
Clinical Trial Update: IL1 Inhibition in FOP
Summary
A clinical trial is evaluating an IL-1–inhibiting therapy for fibrodysplasia ossificans progressiva and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Fibrodysplasia Ossificans Progressiva (FOP) | Status: RECRUITING